共 50 条
- [1] Vinorelbine, Paclitaxel, Etoposide, Cisplatin, and Cytarabine (VTEPA) Is an Effective Second Salvage Therapy for Relapsed/Refractory Hodgkin Lymphoma [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (06): : 657 - 663
- [3] Total Cost of Care in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) [J]. BLOOD, 2022, 140 : 7906 - 7907
- [5] Patient, Caregiver, and Physician Preferences for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S376 - S377
- [8] Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (07): : 474 - 482
- [9] Salvage therapy R-DAOx in patients with relapsed or refractory diffuse large B-CELL lymphoma [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 532 - 532